Jill DeSimone
Director/Board Member at PRAXIS PRECISION MEDICINES, INC.
Net worth: 51 082 $ as of 2024-04-29
Jill DeSimone active positions
Companies | Position | Start | End |
---|---|---|---|
PRAXIS PRECISION MEDICINES, INC. | Director/Board Member | 2022-05-22 | - |
Independent Dir/Board Member | 2022-05-22 | - | |
ONCTERNAL THERAPEUTICS, INC. | Director/Board Member | 2023-01-02 | - |
Independent Dir/Board Member | 2023-01-02 | - | |
ITEOS THERAPEUTICS, INC. | Director/Board Member | 2024-03-06 | - |
Florida Cancer Specialists Foundation, Inc. | Director/Board Member | 2022-03-31 | - |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Director/Board Member | 2022-07-11 | - |
Career history of Jill DeSimone
Former positions of Jill DeSimone
Companies | Position | Start | End |
---|---|---|---|
KINNATE BIOPHARMA INC. | Director/Board Member | 2023-02-28 | 2024-04-02 |
MERCK & CO., INC. | Corporate Officer/Principal | 2013-12-31 | 2022-04-30 |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 2011-12-31 | 2013-12-31 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2005-12-31 | 2011-12-31 |
░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Jill DeSimone
Northeastern University | Undergraduate Degree |
Statistics
International
United States | 12 |
Israel | 2 |
Operational
Director/Board Member | 7 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 2 |
Sectoral
Health Technology | 10 |
Health Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 6 |
---|---|
PRAXIS PRECISION MEDICINES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ONCTERNAL THERAPEUTICS, INC. | Health Technology |
ITEOS THERAPEUTICS, INC. | Health Technology |
Private companies | 5 |
---|---|
Teva Women's Health, Inc.
Teva Women's Health, Inc. Pharmaceuticals: MajorHealth Technology Teva Women's Health, Inc. produces a wide range of women’s healthcare products. Its products include oral contraceptives, intrauterine contraception, and hormone therapy treatments for menopause. The company is headquartered in Woodcliff Lake, NJ. | Health Technology |
The Children's Health Fund
The Children's Health Fund Medical/Nursing ServicesHealth Services The Children's Health Fund is a non-profit organization, which engages in the provision of healthcare services for kids. It offers Blue Bus, a pediatric mobile medical clinic that offers curbside checkups and treatments. The firm also supports the Terra Firma project, a program the provides healthcare, mental health support, and legal assistance for unaccompanied immigrant minors. The company was founded by Irwin E. Redlener, Karen B. Redlener, and Paul Simon in 1987 and is headquartered in New York, NY. | Health Services |
Florida Cancer Specialists Foundation, Inc. | |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Health Technology |
Kinnate Biopharma, Inc.
Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Jill DeSimone
- Experience